HighTower Advisors LLC Has $39.97 Million Holdings in Axon Enterprise, Inc. (NASDAQ:AXON)

HighTower Advisors LLC cut its holdings in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 21.6% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 67,251 shares of the biotechnology company’s stock after selling 18,524 shares during the period. HighTower Advisors LLC owned 0.09% of Axon Enterprise worth $39,968,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors also recently added to or reduced their stakes in the business. Geode Capital Management LLC lifted its position in Axon Enterprise by 2.0% during the 3rd quarter. Geode Capital Management LLC now owns 1,782,828 shares of the biotechnology company’s stock valued at $710,103,000 after purchasing an additional 35,320 shares during the period. Westfield Capital Management Co. LP lifted its position in Axon Enterprise by 12.2% during the 3rd quarter. Westfield Capital Management Co. LP now owns 1,175,328 shares of the biotechnology company’s stock valued at $469,661,000 after purchasing an additional 127,769 shares during the period. Champlain Investment Partners LLC lifted its position in Axon Enterprise by 13.9% during the 3rd quarter. Champlain Investment Partners LLC now owns 682,420 shares of the biotechnology company’s stock valued at $272,695,000 after purchasing an additional 83,265 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its position in Axon Enterprise by 1.6% during the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 561,263 shares of the biotechnology company’s stock valued at $224,281,000 after purchasing an additional 9,090 shares during the period. Finally, Groupama Asset Managment acquired a new position in Axon Enterprise during the 3rd quarter valued at about $200,000. 79.08% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of research analysts have issued reports on the stock. Craig Hallum downgraded shares of Axon Enterprise from a “buy” rating to a “cautious” rating in a research report on Monday. Morgan Stanley raised Axon Enterprise from an “equal weight” rating to an “overweight” rating and upped their price target for the company from $500.00 to $700.00 in a research note on Tuesday, December 3rd. Robert W. Baird upped their price target on Axon Enterprise from $600.00 to $800.00 and gave the company an “outperform” rating in a research note on Friday, December 6th. JMP Securities reaffirmed an “outperform” rating on shares of Axon Enterprise in a research note on Tuesday, February 4th. Finally, Barclays reaffirmed a “hold” rating on shares of Axon Enterprise in a research note on Monday. One analyst has rated the stock with a sell rating, three have issued a hold rating and eleven have given a buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $604.67.

Axon Enterprise Trading Down 4.2 %

NASDAQ:AXON opened at $534.56 on Friday. Axon Enterprise, Inc. has a twelve month low of $273.52 and a twelve month high of $715.99. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. The business has a 50 day moving average price of $595.56 and a two-hundred day moving average price of $532.90. The company has a market cap of $40.96 billion, a P/E ratio of 138.13, a price-to-earnings-growth ratio of 5.17 and a beta of 1.12.

Insiders Place Their Bets

In other news, President Joshua Isner sold 1,291 shares of the stock in a transaction that occurred on Tuesday, December 17th. The stock was sold at an average price of $642.43, for a total value of $829,377.13. Following the completion of the sale, the president now owns 181,892 shares of the company’s stock, valued at approximately $116,852,877.56. This represents a 0.70 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Caitlin Elizabeth Kalinowski sold 450 shares of the stock in a transaction that occurred on Thursday, January 2nd. The shares were sold at an average price of $604.07, for a total value of $271,831.50. Following the completion of the sale, the director now directly owns 6,929 shares of the company’s stock, valued at approximately $4,185,601.03. The trade was a 6.10 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 5,146 shares of company stock valued at $3,262,847 in the last quarter. 6.10% of the stock is currently owned by insiders.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.